DECIDE: A decoupled semantic and boundary learning network for precise osteosarcoma segmentation by integrating

Yinhao Wu1, Jianqi Li2, Xinxin Wang1

  • 1Department of Intelligent Systems Engineering, Sun Yat-sen University, Shenzhen, 518107, China.

Insights

Precise automated osteosarcoma segmentation (AOSMM) is improved by the novel DECIDE network. It effectively fuses multi-modality MRI data and captures complex tumor features for better treatment planning.

Area of Science:

  • Medical Imaging
  • Artificial Intelligence
  • Oncology

Background:

  • Automated Osteosarcoma Segmentation (AOSMM) is crucial for tumor evaluation and treatment planning.
  • Current methods struggle with multi-modality MRI diversity, tumor heterogeneity, and boundary ambiguity.
  • Existing approaches often neglect complementary information from multiple MRI modalities and fail to model long-range tumor feature dependencies.

Purpose of the Study:

  • To develop a precise automated osteosarcoma segmentation method using multi-modality MRI.
  • To address limitations in feature representation and capture complex tumor characteristics.
  • To improve the accuracy and stability of osteosarcoma segmentation.

Main Methods:

  • Proposed a Decoupled Semantic and Boundary Learning Network (DECIDE).
  • Introduced a Multi-modality Feature Fusion and Recalibration (MFR) module for adaptive feature fusion using channel-wise dependencies.
  • Incorporated a Lesion Attention Enhancement (LAE) module for capturing global contextual dependencies and a Boundary Context Aggregation (BCA) module for enhancing semantic representations with boundary information.

Main Results:

  • DECIDE demonstrated exceptional performance in osteosarcoma segmentation.
  • The method surpassed state-of-the-art techniques in accuracy and stability.
  • Experiments confirmed the effectiveness of the MFR, LAE, and BCA modules in improving segmentation precision.

Conclusions:

  • The proposed DECIDE network offers a significant advancement in automated osteosarcoma segmentation.
  • Integrating multi-modality MRI information and advanced attention mechanisms enhances tumor characterization and segmentation accuracy.
  • DECIDE provides a robust and effective solution for clinical applications in osteosarcoma management.